XTuit Pharmaceuticals, Inc. — Form D/A
XTuit Pharmaceuticals, Inc. of WALTHAM, MA, a company, filed a Form D amendment with the SEC on 2015-06-11. The offering totals $22.0M, of which $12.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-06-11
- Form: D/A
- Accession: 0001598271-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $22.0M
- Amount sold: $12.0M
- Remaining: $10.0M
- Investors: 9
- Date of first sale: 2014-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-229519
Issuer
- Name: XTuit Pharmaceuticals, Inc.
- CIK: 0001598271
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 35 Gatehouse Drive, WALTHAM, MA, 02451
- Phone: 617-588-3770
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Alan Crane | Executive Officer | Watertown, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Garry Nicholson | Director | San Diego, CA |
| Garry Nicholson | Executive Officer | San Diego, CA |
| Alan Crane | Director | Watertown, MA |
| Edward Freedman | Executive Officer | Cambridge, MA |
| Rakesh Jain | Director | BERKELEY, CA |
| David Mott | Director | Chevy Chase, MD |
Other filings by this issuer (3)
More